Orchestra BioMed Holdings, Inc. (OBIO) Stock Overview
Explore Orchestra BioMed Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Orchestra BioMed Holdings, Inc. (OBIO)
Key Financials
Key Financials
Market Cap
228.7M
P/E Ratio
-2.69
EPS (TTM)
$-0.97
ROE
-1.38%
OBIO Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Orchestra BioMed Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of OBIO on the NASDAQ shows an RSI of 48.50, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.16 for the NASDAQ listing.
Key metrics behind Orchestra BioMed Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of -2.69 and a market capitalization of 228.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OBIO on the NASDAQ.